Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
10,534,093
-
Share change
-
-263,407
-
Total reported value
-
$66,648,000
-
Price per share
-
$6.32
-
Number of holders
-
23
-
Value change
-
-$1,274,711
-
Number of buys
-
13
-
Number of sells
-
10
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q1 2018
As of 31 Mar 2018,
INTEC PHARMA LTD JERUSALEM - SHS was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,534,093 shares.
The largest 10 holders included
ACUTA CAPITAL PARTNERS, LLC, venBio Select Advisor LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MEITAV DASH INVESTMENTS LTD, Cormorant Asset Management, LP, Migdal Insurance & Financial Holdings Ltd., Sectoral Asset Management Inc, EDMOND DE ROTHSCHILD HOLDING S.A., CAXTON CORP, and OxFORD Asset Management LLP.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.